AcuCort’s strong entrepreneurship and drive, together with a large network of external expertise and business partners, creates good conditions for innovative product and business development.
Potential new indications and products
In addition to the commercialization of ISICORT®/Zeqmelit, AcuCort aims to supplement with additional well-proven and well-documented pharmaceutical substances that suit the company’s business model in indication areas where there is currently a great medical need for new effective and user-friendly treatments.
The starting point according to our business model is that we should prioritize potential products with shorter development periods and higher innovation height where the value development is greatest for a company of our kind. The goal is to develop smart pharmaceutical products and then successfully bring them to market for the benefit of the patients, their families and the community.